Jonathan Kerr

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search
Source: Invest in ME

Jonathan Ricardo Kerr, BSc, MBBCh, MD, PhD, FRCPath, is a British researcher who became interested in ME/CFS after studying the consequences of Parvovirus B19 infection and finding that some of those infected went on to develop CFS. Formerly of St. George’s University of London,[1] he is presently working as an Associate professor in the School of Medicine and Health Sciences at Universidad del Rosario, Bogotá, Colombia.[2]

Notable studies[edit | edit source]

Talks & interviews[edit | edit source]

Invest in ME International ME Conference[edit | edit source]

Online presence[edit | edit source]

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  3. Petty, Robert D.; McCarthy, Nail E.; Le Dieu, Rifca; Kerr, Jonathan R. (2016), "MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME)", PLOS One, doi:10.1371/journal.pone.0150904, PMID 26967895 
  4. Shimosako, Nana; Kerr, Jonathan R. (2014), "Use of single-nucleotide polymorphisms (SNPs) to distinguish gene expression subtypes of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)", Journal of Clinical Pathology, 67 (12), doi:10.1136/jclinpath-2014-202597 
  5. Kerr JR, Gough J, Richards SC, Main J, Enlander D, McCreary M, Komaroff AL, Chia JK. Antibody to parvovirus B19 nonstructural protein is associated with chronic arthralgia in patients with chronic fatigue syndrome/myalgic encephalomyelitis. J Gen Virol. 2010 Apr;91(Pt 4):893-7. doi: 10.1099/vir.0.017590-0
  6. Zhang L, Gough J, Christmas D, et al., Microbial infections in eight genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis. Journal of Clinical Pathology 2010;63:156-164. DOI: 10.1136/jcp.2009.072561
  7. J R Kerr, P Christian, A Hodgetts, P R Langford, L D Devanur, R Petty, B Burke, L I Sinclair, S C M Richards, J Montgomery, C R McDermott, T J Harrison, P Kellam, D J Nutt, S T Holgate, and the Collaborative Clinical Study Group (2007) Current research priorities in chronic fatigue syndrome/myalgic encephalomyelitis: disease mechanisms, a diagnostic test and specific treatments, JOURNAL OF CLINICAL PATHOLOGY, Vol: 60, Pages: 113-116, DOI: 10.1136/jcp.2006.042374
  8. Kaushik, N., Fear, D., Richards, S. C. M., McDermott, C. R., Nuwaysir, E. F., Kellam, P., … Kerr, J. R. (2005). Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome. Journal of Clinical Pathology, 58(8), 826–832.
  9. Smith, J., Fritz, E. L., Kerr, J. R., Cleare, A. J., Wessely, S., & Mattey, D. L. (2005). Association of chronic fatigue syndrome with human leucocyte antigen class II alleles. Journal of Clinical Pathology, 58(8), 860–863.
  10. Jonathan R. Kerr, Ann-Marie Barrett, Martin D. Curran, Wilhelmina M. H. Behan, Derek Middleton, and P.O. Behan. (1997). Parvovirus B19 and Chronic Fatigue Syndrome. Journal of Chronic Fatigue Syndrome, Vol. 3, Iss. 3, pp 101-107. doi:10.1300/J092v03n03_07

The information provided at this site is not intended to diagnose or treat any illness.

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history